Zerizer, Imene
15  results:
Search for persons X
?
 
?
4

The Young EANM Committee survey:

Ekmekcioglu, Ozgul ; Zerizer, Imene ; Pilkington, Patrick...
European Journal of Nuclear Medicine and Molecular Imaging.  43 (2015)  3 - p. 601-603 , 2015
 
?
6

Imaging the future: a report from the Young Daily EANM Foru..:

Cicone, Francesco ; Jamar, François ; Zerizer, Imene
European Journal of Nuclear Medicine and Molecular Imaging.  41 (2014)  4 - p. 811-812 , 2014
 
?
7

Positron Emission Tomography-Computed Tomography in Liver I..:

Sharma, Bhuey ; Martin, Axel ; Zerizer, Imene
Seminars in Ultrasound, CT and MRI.  34 (2013)  1 - p. 66-80 , 2013
 
?
 
?
9

Highlights of the EANM Congress 2011: Birmingham, UK:

de Geus-Oei, Lioe-Fee ; Zerizer, Imene ; Uebleis, Christopher.
European Journal of Nuclear Medicine and Molecular Imaging.  39 (2012)  2 - p. 354-368 , 2012
 
?
10

Don't blame the bones!:

Zerizer, Imene ; Cameron, Jane ; Kon, Onn Min..
European Journal of Nuclear Medicine and Molecular Imaging.  38 (2010)  1 - p. 191-191 , 2010
 
?
12

Role of FDG-PET and PET/CT in the diagnosis and management ..:

Zerizer, Imene ; Tan, Kathryn ; Khan, Sameer...
European Journal of Radiology.  73 (2010)  3 - p. 504-509 , 2010
 
?
 
?
14

CHOP versus GEM-P in previously untreated patients with per..:

Gleeson, Mary ; Peckitt, Clare ; To, Ye Mong...
https://eprints.soton.ac.uk/420538/1/1_s2.0_S2352302618300395_main.pdf.  , 2018
 
?
15

CHOP versus GEM-P in previously untreated patients with per..:

Gleeson, Mary ; Peckitt, Clare ; To, Ye Mong...
Gleeson , M , Peckitt , C , To , Y M , Edwards , L , Oates , J , Wotherspoon , A , Attygalle , A D , Zerizer , I , Sharma , B , Chua , S , Begum , R , Chau , I , Johnson , P , Ardeshna , K M , Hawkes , E A , Macheta , M P , Collins , G P , Radford , J , Forbes , A , Hart , A , Montoto , S , McKay , P , Benstead , K , Morley , N , Kalakonda , N , Hasan , Y , Turner , D & Cunningham , D 2018 , ' CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T) : a phase 2, multicentre, randomised, open-label trial ' , The Lancet Haematology , vol. 5 , no. 5 , pp. e190-e200 . https://doi.org/10.1016/S2352-3026(18)30039-5.  , 2018
 
1-15